Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared.

作者: Jason Rotter , Jennifer C. Spencer , Stephanie B. Wheeler

DOI: 10.1200/JOP.18.00518

关键词:

摘要: Patients with metastatic or advanced cancer are likely to be particularly susceptible financial hardship for reasons related both the characteristics of disease and population living disease. First, is a resource-intensive condition expensive treatment consistent, high-intensity monitoring. Second, patients diagnosed disproportionately uninsured low income from racial ethnic minority groups. These vulnerable subpopulations have higher burden even in earlier stages illness, potentially resulting fewer asset reserves, nonexisting less generous health insurance benefits, employment jobs flexibility protections. This combination high need vulnerability makes those an important additional study. In this article, we summarize why toxicity burdensome disease; review prior work settings specifically; close implications recommendations research, practice, policy.

参考文章(55)
S Yousuf Zafar, Amy P Abernethy, Financial toxicity, Part II: how can we help with the burden of treatment-related costs? Oncology. ,vol. 27, pp. 253- 256 ,(2013)
Karen Gerard, Mandy Ryan, Using discrete choice experiments to value health care programmes: current practice and future research reflections. Applied Health Economics and Health Policy. ,vol. 2, pp. 55- 64 ,(2003)
S Jane Henley, Jessica B King, Robert R German, Lisa C Richardson, Plescia M, Centers for Disease Control and Prevention (CDC), Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006 Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002). ,vol. 59, pp. 1- 25 ,(2010)
Yuda Chongpison, Mark C. Hornbrook, Robin B. Harris, Lisa J. Herrinton, Joe K. Gerald, Marcia Grant, Joanna E. Bulkley, Christopher S. Wendel, Robert S. Krouse, Self-reported depression and perceived financial burden among long-term rectal cancer survivors Psycho-Oncology. ,vol. 25, pp. 1350- 1356 ,(2016) , 10.1002/PON.3957
Scott Ramsey, Veena Shankaran, Managing the financial impact of cancer treatment: the role of clinical practice guidelines. Journal of The National Comprehensive Cancer Network. ,vol. 10, pp. 1037- 1042 ,(2012) , 10.6004/JNCCN.2012.0106
Reginald D. Tucker-Seeley, Gregory A. Abel, Hajime Uno, Holly Prigerson, Financial hardship and the intensity of medical care received near death Psycho-oncology. ,vol. 24, pp. 572- 578 ,(2015) , 10.1002/PON.3624
Michael D. Clark, Domino Determann, Stavros Petrou, Domenico Moro, Esther W. de Bekker-Grob, Discrete Choice Experiments in Health Economics: A Review of the Literature PharmacoEconomics. ,vol. 32, pp. 883- 902 ,(2014) , 10.1007/S40273-014-0170-X
Koonal K. Shah, Aki Tsuchiya, Allan J. Wailoo, Valuing health at the end of life: a stated preference discrete choice experiment. Social Science & Medicine. ,vol. 124, pp. 48- 56 ,(2015) , 10.1016/J.SOCSCIMED.2014.11.022
Åke Blomqvist, The doctor as double agent: information asymmetry, health insurance, and medical care. Journal of Health Economics. ,vol. 10, pp. 411- 432 ,(1991) , 10.1016/0167-6296(91)90023-G
Katherine E. Reeder-Hayes, Stephanie B. Wheeler, Deborah K. Mayer, HEALTH DISPARITIES ACROSS THE BREAST CANCER CONTINUUM Seminars in Oncology Nursing. ,vol. 31, pp. 170- 177 ,(2015) , 10.1016/J.SONCN.2015.02.005